DSCAM-AS1 and breast carcinoma: Annotated lncRNAs already implicated in breast cancer (DSCAM-AS1, NEAT1, SNHG3, ZFAS1) also had a significant (FDR ≤ 0.3) effect, indicating the screen was able to identify functional lncRNAs.